CompletedNCT03623295
The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B
Studying Mild hemophilia B
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator
- Karin FijnvandraatAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Intervention
- Blood sample(other)
- Enrollment
- 304 enrolled
- Eligibility
- 12-55 years · MALE
- Timeline
- 2018 – 2021
Study locations (17)
- Royal Adelaide Hospital, Adelaide, Australia
- Medical University of Vienna, Vienna, Austria
- Multicentre: Leuven, Brussels, Multiple Locations, Belgium
- Multicentre: Vancouver, Toronto, Hamilton, Multiple Locations, Canada
- Helsinki University Central Hospital, Helsinki, Finland
- Multicentre: Bonn, Berlin, Frankfurt, München, Hamburg, Multiple Locations, Germany
- Multicentre: Florence, Rome, Parma, Milan, Turin, Multiple Locations, Italy
- Academic Medical Center, Amsterdam, Netherlands
- University Medical Center Groningen, Groningen, Netherlands
- Leiden University Medical Center, Leiden, Netherlands
- Maastricht University Medical Center, Maastricht, Netherlands
- Radboud University Medical Center, Nijmegen, Netherlands
- Erasmus Medical Center, Rotterdam, Netherlands
- Utrecht University Medical Center, Utrecht, Netherlands
- Máxima Medical Center, Veldhoven, Netherlands
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03623295 on ClinicalTrials.gov